drugset / Trial / NCT00621153
Candesartan Effect in Second Stage Arterial Hypertension
RandomizedParallel-groupOpen-labelTreatment
Summary
To compare the changes in mean sitting DBP from baseline after 4 weeks of therapy with either candesartan cilexetil/HCT combination therapy or candesartan cilexetil monotherapy regimen
Timeline
- Start
- 2008-02
- Primary completion
- 2009-03
- Completion
- 2009-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Candesartan cilexetil | Unknown | 16 mg | Oral |
| Subject | Candesartan cilexetil | Unknown | 32 mg | Oral |
| Subject | Hydrochlorothiazide | Unknown | 12.5 mg | — |